FINWIRES · TerminalLIVE
FINWIRES

研究快讯:丹:第一季度业绩超出预期;维持2026年业绩指引

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下: Dana Incorporated (DAN)公布的第一季度调整后EBITDA为1.71亿美元,高于此前预期的9300万美元(增长84%),也高于市场普遍预期的1.6亿美元。营收增长5%至18.7亿美元(比市场预期高出4000万美元),调整后EBITDA利润率提升400个基点至9.2%(比市场预期高出40个基点)。DAN第一季度调整后EBITDA利润率的提升主要得益于成本节约和效率提升。管理层表示,公司在第一季度实现了3500万美元的额外成本节约。DAN重申了此前发布的2026年业绩指引,管理层表示,Dana 2030计划清晰地规划了实现更高销售额、更高利润率和更多调整后自由现金流的路径。 DAN公司表示,第一季度回购了440万股股票,耗资1.25亿美元。该公司目前还支付每股0.48美元的年度股息。消息公布后,DAN的股价几乎没有变化。2025年,DAN的表现远超其他汽车零部件供应商(涨幅达110%,而标普500指数同期涨幅仅为16%),我们认为管理层在利润率方面取得的显著进展以及积极的股票回购计划都是利好因素。

Related Articles

Australia

Mizuho Securities Raises Price Target on Apellis Pharmaceuticals to $41 From $20, Maintains Neutral Rating

Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%

$APLS
Research

Mizuho Securities Downgrades Terns Pharmaceuticals to Neutral From Outperform, Trims Price Target to $53 From $54

Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.

$TERN
Research

Research Alert: CFRA Reiterates Buy Opinion On Shares Of Booking Holdings Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $196, 19x our 2026 EPS estimate (unchanged) and a discount to its 23x five-year average forward multiple, reflecting geopolitical risks. We lower our 2026 EPS to $10.33 from $10.74 and 2027's to $11.58 from $12.07, primarily reflecting lower gross bookings growth from the Middle East conflict. We maintain our Buy opinion as shares are undervalued given long-term competitive strengths and temporary geopolitical headwinds. The company's Connected Trip platform and Genius loyalty program are supporting higher-margin direct bookings, suggesting AI initiatives are strengthening consumer engagement rather than disintermediating the platform. Strong free cash flow supports future shareholder returns, including $3.6 billion in Q1 buybacks. While the Middle East conflict will impact Q2 bookings, BKNG has a history of seeing travel rebound following geopolitical or economic disruptions. U.S. room night growth accelerated in Q1 to a low-teens range, providing near-term momentum.

$BKNG